These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29042278)

  • 41. Antitumor action of seminal ribonuclease, its dimeric structure, and its resistance to the cytosolic ribonuclease inhibitor.
    Antignani A; Naddeo M; Cubellis MV; Russo A; D'Alessio G
    Biochemistry; 2001 Mar; 40(12):3492-6. PubMed ID: 11297415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of ribonuclease multimers created by site-specific covalent tethering.
    Rutkoski TJ; Kink JA; Strong LE; Schilling CI; Raines RT
    Bioconjug Chem; 2010 Sep; 21(9):1691-702. PubMed ID: 20704261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the interaction of ribonuclease inhibitor with pancreatic ribonuclease involving differential labeling of cysteinyl residues.
    Hofsteenge J; Servis C; Stone SR
    J Biol Chem; 1991 Dec; 266(35):24198-204. PubMed ID: 1748689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The swapping of terminal arms in ribonucleases: comparison of the solution structure of monomeric bovine seminal and pancreatic ribonucleases.
    Avitabile F; Alfano C; Spadaccini R; Crescenzi O; D'Ursi AM; D'Alessio G; Tancredi T; Picone D
    Biochemistry; 2003 Jul; 42(29):8704-11. PubMed ID: 12873130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ribonuclease A can be transformed into a dimeric ribonuclease with antitumor activity.
    Di Donato A; Cafaro V; D'Alessio G
    J Biol Chem; 1994 Jul; 269(26):17394-6. PubMed ID: 8021240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional role of glutamine 28 and arginine 39 in double stranded RNA cleavage by human pancreatic ribonuclease.
    Rehman MT; Dey P; Hassan MI; Ahmad F; Batra JK
    PLoS One; 2011 Mar; 6(3):e17159. PubMed ID: 21408145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.
    Gotte G; Menegazzi M
    Front Immunol; 2019; 10():2626. PubMed ID: 31849926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endowing human pancreatic ribonuclease with toxicity for cancer cells.
    Leland PA; Staniszewski KE; Kim BM; Raines RT
    J Biol Chem; 2001 Nov; 276(46):43095-102. PubMed ID: 11555655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor activity and other biological actions of oligomers of ribonuclease A.
    Matousek J; Gotte G; Pouckova P; Soucek J; Slavik T; Vottariello F; Libonati M
    J Biol Chem; 2003 Jun; 278(26):23817-22. PubMed ID: 12697760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant.
    Merlino A; Avella G; Di Gaetano S; Arciello A; Piccoli R; Mazzarella L; Sica F
    Protein Sci; 2009 Jan; 18(1):50-7. PubMed ID: 19177350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of unique basic residues of human pancreatic ribonuclease in its catalysis and structural stability.
    Dey P; Islam A; Ahmad F; Batra JK
    Biochem Biophys Res Commun; 2007 Sep; 360(4):809-14. PubMed ID: 17631275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A ribonuclease A variant with low catalytic activity but high cytotoxicity.
    Bretscher LE; Abel RL; Raines RT
    J Biol Chem; 2000 Apr; 275(14):9893-6. PubMed ID: 10744660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein engineering of ribonucleases.
    Cafaro V; Bracale A; Formiggini F; Notomista E; D'Alessio G; Di Donato A
    Biochimie; 1998 Nov; 80(11):905-9. PubMed ID: 9893950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of bovine pancreatic ribonuclease (RNase A) inhibit growth of human melanoma in nude mice.
    Soucek J; Poucková P; Strohalm J; Plocová D; Hlousková D; Zadinová M; Ulbrich K
    J Drug Target; 2002 May; 10(3):175-83. PubMed ID: 12075818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocytotic internalization as a crucial factor for the cytotoxicity of ribonucleases.
    Leich F; Stöhr N; Rietz A; Ulbrich-Hofmann R; Arnold U
    J Biol Chem; 2007 Sep; 282(38):27640-6. PubMed ID: 17635931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study of the intracellular routing of cytotoxic ribonucleases.
    Wu Y; Saxena SK; Ardelt W; Gadina M; Mikulski SM; De Lorenzo C; D'Alessio G; Youle RJ
    J Biol Chem; 1995 Jul; 270(29):17476-81. PubMed ID: 7542240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ribonuclease inhibitor as an intracellular sentry.
    Haigis MC; Kurten EL; Raines RT
    Nucleic Acids Res; 2003 Feb; 31(3):1024-32. PubMed ID: 12560499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicity.
    Monti DM; D'Alessio G
    J Biol Chem; 2004 Sep; 279(38):39195-8. PubMed ID: 15277533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural basis for the biological activities of bovine seminal ribonuclease.
    Kim JS; Soucek J; Matousek J; Raines RT
    J Biol Chem; 1995 May; 270(18):10525-30. PubMed ID: 7737987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A misfolded but active dimer of bovine seminal ribonuclease.
    Kim JS; Raines RT
    Eur J Biochem; 1994 Aug; 224(1):109-14. PubMed ID: 8076630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.